Stay updated with breaking news from Kodiak Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...
Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 1,170,000 shares, a decline of 13.3% from the February 28th total of 1,350,000 shares. Based on an average daily trading volume, of 283,300 shares, the days-to-cover ratio […]
PALO ALTO, Calif., March 28, 2023 /PRNewswire/ -- Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat... | March 28, 2023
Kodiak Sciences Inc. (KOD) released Loss for fourth quarter that decreased from the same period last year and beat the Street estimates. The company's earnings totaled -$70.
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...